Cargando…

Triptolide inhibits the progression of Glioblastoma U251 cells via targeting PROX1

BACKGROUND: Glioblastoma multiforme (GBM) is the most lethal brain cancer in adults, characterized by rapid growth, extensive invasiveness, and poor prognosis, and there is still a lack of effective treatments. Here, we aimed to explore the role of triptolide (TPL), purified from Tripterygium wilfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Chao, Liao, Yanli, Liao, Shengjie, Huang, Mi, Li, Duanzhuo, Wu, Weibin, Quan, Yi, Li, Liqiang, Yu, Xin, Si, Wenxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038275/
https://www.ncbi.nlm.nih.gov/pubmed/36969058
http://dx.doi.org/10.3389/fonc.2023.1077640
_version_ 1784912044067127296
author Yuan, Chao
Liao, Yanli
Liao, Shengjie
Huang, Mi
Li, Duanzhuo
Wu, Weibin
Quan, Yi
Li, Liqiang
Yu, Xin
Si, Wenxia
author_facet Yuan, Chao
Liao, Yanli
Liao, Shengjie
Huang, Mi
Li, Duanzhuo
Wu, Weibin
Quan, Yi
Li, Liqiang
Yu, Xin
Si, Wenxia
author_sort Yuan, Chao
collection PubMed
description BACKGROUND: Glioblastoma multiforme (GBM) is the most lethal brain cancer in adults, characterized by rapid growth, extensive invasiveness, and poor prognosis, and there is still a lack of effective treatments. Here, we aimed to explore the role of triptolide (TPL), purified from Tripterygium wilfordii Hook F, on glioblastoma cell growth, apoptosis, proliferation, migration and invasion, as well as potential underlying mechanisms. METHODS: The publicly available clinical data of Brain Lower Grade Glioma (LGG) from The Cancer Genome Atlas (TCGA) had been screened to observe PROX1 expression. The Kaplan-Meier analysis was used to analyze the relationship between PROX1 expression and GBM prognosis. CCK8, cell cycle, EDU, apoptosis, wound healing, and transwell assays were performed to detect the effects of TPL on glioblastoma U251 cell viability, cell cycle, proliferation, apoptosis, migration and invasion, respectively. Further, a soft agar colony assay was used to calculate the growth of glioblastoma cells. The qRT-PCR and western blot were conducted to quantify PROX1 mRNA and protein levels. The transcriptional regulation of TPL was detected by Dual luciferase reporter assay. RESULTS: We found that TPL inhibited glioblastoma cell viability, proliferation, cell cycle, migration and invasion, but enhanced apoptosis in a dose-dependent manner. The expression of cell cycle inhibitor, P21, and pro-apoptosis factor, Bax was increased, while invasion-related factors MMP2 and MMP9 were silenced after TPL treatments. Mechanistically, TPL showed transcriptional inhibition of PROX1 appearance. Moreover, ectopic expression of PROX1 partially rescued the effects of TPL on glioblastoma cell viability, proliferation, apoptosis, migration and invasion, and on the expression of cell function-related genes. CONCLUSION: This study verified that TPL inhibited the progression of glioblastoma cells by transcriptionally depressing the expression of PROX1.
format Online
Article
Text
id pubmed-10038275
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100382752023-03-25 Triptolide inhibits the progression of Glioblastoma U251 cells via targeting PROX1 Yuan, Chao Liao, Yanli Liao, Shengjie Huang, Mi Li, Duanzhuo Wu, Weibin Quan, Yi Li, Liqiang Yu, Xin Si, Wenxia Front Oncol Oncology BACKGROUND: Glioblastoma multiforme (GBM) is the most lethal brain cancer in adults, characterized by rapid growth, extensive invasiveness, and poor prognosis, and there is still a lack of effective treatments. Here, we aimed to explore the role of triptolide (TPL), purified from Tripterygium wilfordii Hook F, on glioblastoma cell growth, apoptosis, proliferation, migration and invasion, as well as potential underlying mechanisms. METHODS: The publicly available clinical data of Brain Lower Grade Glioma (LGG) from The Cancer Genome Atlas (TCGA) had been screened to observe PROX1 expression. The Kaplan-Meier analysis was used to analyze the relationship between PROX1 expression and GBM prognosis. CCK8, cell cycle, EDU, apoptosis, wound healing, and transwell assays were performed to detect the effects of TPL on glioblastoma U251 cell viability, cell cycle, proliferation, apoptosis, migration and invasion, respectively. Further, a soft agar colony assay was used to calculate the growth of glioblastoma cells. The qRT-PCR and western blot were conducted to quantify PROX1 mRNA and protein levels. The transcriptional regulation of TPL was detected by Dual luciferase reporter assay. RESULTS: We found that TPL inhibited glioblastoma cell viability, proliferation, cell cycle, migration and invasion, but enhanced apoptosis in a dose-dependent manner. The expression of cell cycle inhibitor, P21, and pro-apoptosis factor, Bax was increased, while invasion-related factors MMP2 and MMP9 were silenced after TPL treatments. Mechanistically, TPL showed transcriptional inhibition of PROX1 appearance. Moreover, ectopic expression of PROX1 partially rescued the effects of TPL on glioblastoma cell viability, proliferation, apoptosis, migration and invasion, and on the expression of cell function-related genes. CONCLUSION: This study verified that TPL inhibited the progression of glioblastoma cells by transcriptionally depressing the expression of PROX1. Frontiers Media S.A. 2023-03-10 /pmc/articles/PMC10038275/ /pubmed/36969058 http://dx.doi.org/10.3389/fonc.2023.1077640 Text en Copyright © 2023 Yuan, Liao, Liao, Huang, Li, Wu, Quan, Li, Yu and Si https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yuan, Chao
Liao, Yanli
Liao, Shengjie
Huang, Mi
Li, Duanzhuo
Wu, Weibin
Quan, Yi
Li, Liqiang
Yu, Xin
Si, Wenxia
Triptolide inhibits the progression of Glioblastoma U251 cells via targeting PROX1
title Triptolide inhibits the progression of Glioblastoma U251 cells via targeting PROX1
title_full Triptolide inhibits the progression of Glioblastoma U251 cells via targeting PROX1
title_fullStr Triptolide inhibits the progression of Glioblastoma U251 cells via targeting PROX1
title_full_unstemmed Triptolide inhibits the progression of Glioblastoma U251 cells via targeting PROX1
title_short Triptolide inhibits the progression of Glioblastoma U251 cells via targeting PROX1
title_sort triptolide inhibits the progression of glioblastoma u251 cells via targeting prox1
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038275/
https://www.ncbi.nlm.nih.gov/pubmed/36969058
http://dx.doi.org/10.3389/fonc.2023.1077640
work_keys_str_mv AT yuanchao triptolideinhibitstheprogressionofglioblastomau251cellsviatargetingprox1
AT liaoyanli triptolideinhibitstheprogressionofglioblastomau251cellsviatargetingprox1
AT liaoshengjie triptolideinhibitstheprogressionofglioblastomau251cellsviatargetingprox1
AT huangmi triptolideinhibitstheprogressionofglioblastomau251cellsviatargetingprox1
AT liduanzhuo triptolideinhibitstheprogressionofglioblastomau251cellsviatargetingprox1
AT wuweibin triptolideinhibitstheprogressionofglioblastomau251cellsviatargetingprox1
AT quanyi triptolideinhibitstheprogressionofglioblastomau251cellsviatargetingprox1
AT liliqiang triptolideinhibitstheprogressionofglioblastomau251cellsviatargetingprox1
AT yuxin triptolideinhibitstheprogressionofglioblastomau251cellsviatargetingprox1
AT siwenxia triptolideinhibitstheprogressionofglioblastomau251cellsviatargetingprox1